Works matching IS 09733930 AND DT 2024 AND VI 44 AND IP 3


Results: 26
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Empagliflozin combined with short-term intensive insulin therapy improves glycemic variability and 1,5-anhydroglucitol in patients with type 2 diabetes: a randomized clinical trial.

    Published in:
    International Journal of Diabetes in Developing Countries, 2024, v. 44, n. 3, p. 486, doi. 10.1007/s13410-023-01271-8
    By:
    • Hao, Zhihua;
    • Zhao, Yuliang;
    • Zhu, Qiuxiao;
    • Ge, Yanhong;
    • Liu, Zibo;
    • Chen, Yanxia;
    • Jiao, Lijing;
    • Zhao, Xin;
    • Wang, Xing;
    • Wang, Jing;
    • Zhou, Jing;
    • Hao, Huiyao;
    • Hao, Yongmei;
    • Zhou, Hong;
    • Wang, Mian;
    • Zhang, Lihui
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Evaluation of HbA1c levels as probable diagnostic of depression symptoms in Mexican individuals with type 2 diabetes mellitus.

    Published in:
    International Journal of Diabetes in Developing Countries, 2024, v. 44, n. 3, p. 585, doi. 10.1007/s13410-023-01232-1
    By:
    • Juárez-Rojop, Isela Esther;
    • Tovilla-Vidal, Gisselle;
    • López-Narváez, María Lilia;
    • Tovilla-Zárate, Carlos Alfonso;
    • Rodríguez-Sánchez, Esther;
    • González-Castro, Thelma Beatriz;
    • Fresán, Ana;
    • Ramírez-González, Dania;
    • Hernández-Díaz, Yazmín
    Publication type:
    Article
    24
    25
    26